• About ArQule
• Product R & D
• Clinical Trials
• Investors and Media
  • Press Releases
  • Events
  • Corporate Presentation
  • Recent Data Presentations
  • Corporate Governance
  • Financial Information
  • Stock Information
  • Contact Us
• Careers

Recent Data Presentations

ASCO - June 2010

ARQ197-209 ASCO Poster  1.2 MB   116 ASCO Poster 580.7 KB   ARQ 197-114 ASCO Poster 353.0 KB   ARQ 197-215 ASCO Poster 345.5 KB

2010 Gastrointestinal Cancers Symposium - January 2010

A Phase 1b Safety Study of ARQ 197 in Cirrhotic Patients with Hepatocellular Carcinoma (ARQ 197-114)  2.2 MB

The 13th World Lung Conference - August 2009

Phase 1 Dose Escalation Trial (ARQ197-111) Evaluating Combination of Selective c-MET Inhibitor ARQ 197 and Erlotinib  1.8 MB

ASCO - June 2009

Phase 1 Dose Escalation Trial (ARQ 197-111) Evaluating Combination of Selective c-MET Inhibitor ARQ 197 and Erlotinib 179.7 KB   Final Results: A Dose Escalation Phase 1 Study of ARQ 197, a Selective c-MET Inhibitor, in Patients with Metastatic Solid Tumors 494.4 KB   Preliminary Results from a Phase 2 Study of ARQ 197 in Patients with Microphthalmia Transcription Factor Family (MiT) Associated Tumors  1.0 MB   Final Results of a Pharmacokinetic and Pharmacodynamic Phase I Trial of ARQ 197 946.4 KB

= add file to Briefcase